The health of adolescents worldwide is at a critical juncture, warns a new analysis published by The Lancet Commission, ...

We're replacing BBC Sounds outside the UK and bringing you BBC.com, a seamless way to read, watch, and listen - all in one place. We use cookies to give you the best online experience. Strictly ...

In India, the incidence of overweight and obesity is increasing, with recent estimates showing that 24% of women and 23% of men are overweight or obese. With lifestyle-based diseases on the rise, it ...

RBC Capital Markets Global Healthcare Conference May 21, 2025 9:00 AM ETCompany ParticipantsJustin Claeys - VP, IRKave Niksefat ...

After adjusting for the weight loss benefits of surgery, GLP-1 drugs were linked to a 41% lower risk of obesity-related ...

A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but without diabetes, highlighting its superior effectiveness and cardiometabolic ...

The Trump administration approved a first-of-its-kind waiver for Nebraska to ban purchases of soda and energy drinks with ...

Heart failure is a progressive condition that occurs when the heart muscle is damaged and can no longer pump enough blood and oxygen to the body’s other organs. It’s extremely common in the US, with ...

A sleep medicine specialist explains how restless nights lead to consuming more calories and how you can use sleep as a tool ...

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

The pricey medications remain out of reach for millions of patients across the country who could benefit from them.

GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL.